...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >European Society of Gynecological Oncology Task Force for Fertility Preservation Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients
【24h】

European Society of Gynecological Oncology Task Force for Fertility Preservation Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients

机译:欧洲妇科肿瘤学会生育保护特别工作组对年轻子宫内膜癌患者节约生育的临床建议

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endometrial cancer (EC) in young women of reproductive age is a relatively rare diagnosis. However, since in the modern era women delay their childbearing for a variety of social reasons, more and more women in the near future will be nulliparous and have a diagnosis of EC at the same time. Hence, a more conservative approach of EC is desirable to preserve fertility of these women, without compromising their survival. Recently, the number of studies reporting encouraging results on fertility-sparing management of EC with high dose of progestins is increasing. It seems that preserving the uterus and the ovaries in a carefully selected patient with EC confers only a very small risk combined with an enormous benefit. Selection of women suitable for such a conservative approach, as well as method of treatment, follow-up, recurrence, obstetric outcomes, and survival rates are very important parameters when consulting women with EC wishing to preserve their fertility. In this article, we try to elucidate all the previously mentioned aspects and formulate clinical recommendations, based on published data, about the most proper approach and consultation of these patients.
机译:子宫内膜癌(EC)在育龄的年轻女性中是一种相对罕见的诊断。然而,由于在现代时代,妇女由于各种社会原因推迟生育,所以在不久的将来,越来越多的妇女将是未生育的并且同时患有EC。因此,需要一种更为保守的EC方法,以保持这些妇女的生育能力而不损害其生存能力。最近,报告在使用高剂量孕激素的EC的保胎管理方面令人鼓舞的结果的研究数量正在增加。看来,精心挑选的EC患者保留子宫和卵巢只会带来很小的风险,并带来巨大的好处。在咨询希望保留生育能力的乳癌妇女时,选择适合这种保守方法的妇女以及治疗方法,随访,复发,产科结局和生存率是非常重要的参数。在本文中,我们试图阐明所有先前提到的方面,并根据已公开的数据针对这些患者的最适当方法和咨询提供临床建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号